Alison Kodjak
-
Certain high-cost drugs are straining state budgets. A new deal approved Wednesday allows Louisiana to spend a fixed amount for unlimited access to a costly cure. Other states may try to follow suit. -
A quirk in the law gives an older opioid addiction treatment "orphan drug" status — and a period of exclusive market access. That may prevent some new therapies from reaching patients for years. -
Lawmakers in the House and Senate are pressing companies to lower prices for insulin which is essential for many people with diabetes. The price is 10 times higher today than it was 20 years ago.
-
A federal judge has struck down a Medicaid work requirement in Arkansas and Kentucky. This is a major blow to the Trump administration's vision for the health insurance program for low-income people.
-
Justice Department files notice that it agrees with a federal judge's ruling that the ACA should be thrown out. The administration had previously said it wanted only parts of the law invalidated.
-
The Trump administration wants to increase transparency in prescription drug pricing. But health economists say the administration's call to tie prices to what other nations pay might work better. -
The CEOs of seven U.S. drug makers testified before the Senate Finance Committee on their pricing practices.
-
Democratic Sen. Kamala Harris, who's a candidate for the 2020 presidential election, has endorsed "Medicare for all." But the details of what that means are rather elusive.
-
A federal judge in Texas issued a ruling Friday declaring the Affordable Care Act unconstitutional, apparently setting the stage for another hearing on the health care law by the U.S. Supreme Court.
-
A Texas judge on Friday said that the Affordable Care Act is unconstitutional — a ruling likely to be appealed and to make its way up to the Supreme Court.
